These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1017532)

  • 1. Cell-mediated immunity in epidermodysplasia verruciformis.
    Gliński W; Jablonska S; Langner A; Obalek S; Haftek M; Proniewska M
    Dermatologica; 1976; 153(4):218-27. PubMed ID: 1017532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis.
    Pereira de Oliveira WR; Carrasco S; Neto CF; Rady P; Tyring SK
    J Dermatol; 2003 Mar; 30(3):203-9. PubMed ID: 12692356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5.
    Gliński W; Obałek S; Jabłońska S; Orth G
    Dermatologica; 1981; 162(3):141-7. PubMed ID: 6265297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity (CMI) in psoriasis.
    Gliński W; Haftek M; Obałek S; Jabłońska S
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):755-60. PubMed ID: 312084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on cell-mediated immunity in patients with different warts.
    Obałek S; Gliński W; Haftek M; Orth G; Jabłońska S
    Dermatologica; 1980; 161(2):73-83. PubMed ID: 7398987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidermodysplasia verruciformis (2 cases). Immunological study (author's transl)].
    Guilhou JJ; Malbos S; Barnéon S; Habib A; Baldet P; Meynadier J
    Ann Dermatol Venereol; 1980 Jul; 107(7):611-9. PubMed ID: 6254427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
    Sasaki T; Fujisaki S
    Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reactivity of women on hormonal contraceptives. Phytohemagglutinin and concanavalin-A induced lymphocyte response.
    Gerretsen G; Kremer J; Bleumink E; Nater JP; de Gast GC; The TH
    Contraception; 1980 Jul; 22(1):25-9. PubMed ID: 7418405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adherent cells in immune responses to phytohemagglutinin and concanavalin A.
    Arala-Chaves MP; Hope L; Korn JH; Fudenberg H
    Eur J Immunol; 1978 Feb; 8(2):77-81. PubMed ID: 306923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
    Hsu MM; Lin BL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible nonspecific immunopotentiation by 2,4-dinitrochlorobenzene sensitization in patients with Hodgkin's disease.
    Rubinstein A; Ghossein NA; Melamed J; Bosworth JL; Murphy RA
    Oncology; 1979; 36(1):23-6. PubMed ID: 313034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative cell-mediated immune status of gastric cancer patients.
    Orita K; Miwa H; Fukuda H; Yumura M; Uchida Y
    Cancer; 1976 Dec; 38(6):2343-8. PubMed ID: 793709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing age.
    Foad BS; Khullar S; Freimer EH; Kirsner AB; Sheon RP
    J Lab Clin Med; 1975 Jan; 85(1):132-9. PubMed ID: 49381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S; Haftek M; Sliński W
    Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of delayed hypersensitivity responses in normal horses and immunodeficient foals.
    Hodgin EC; McGuire TC; Perryman LE; Grant BD
    Am J Vet Res; 1978 Jul; 39(7):1161-7. PubMed ID: 677535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to cytomegalovirus in pregnant women.
    Agatsuma Y; Fitzpatrick P; Lele A; Kaul A; Ogra PL
    Am J Reprod Immunol (1980); 1981 Aug; 1(4):174-9. PubMed ID: 6278969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity in Hurler's syndrome.
    Mendes E; Toledo SP
    Allergol Immunopathol (Madr); 1975; 3(2):95-8. PubMed ID: 808113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.